Race Oncology Completes $3.22m Private Placement

● Placement undertaken by a group of existing sophisticated shareholders at the 5-day volume weight average price of $2.83, a 6% premium to the closing price of $2.67 on 8 December 2025 ● HARNESS-1 first patient expected to be enrolled early Q1 2026. 9 December 2025 – Race Oncology Limited (“Race”) is pleased to announce it has received and accepted an offer of a private placement (Placement) from